Nabila Noor, MD
Urogynecology and Reconstructive Pelvic Surgery · Allentown, PANPI 1114226396
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,628 of the $7,140 with a category attached, or 64.8%. Medtronic accounts for 65.5% of it on its own, with 5 other manufacturers making up the rest. 2025 is the largest year on record at $2,450, more than ten times the $91 reported in 2019.
Across 122 payments — averaging $58.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$5K
- Boston Scientific$2K
- Coloplast$526
- Axonics, Inc.$204
- Urovant Sciences Inc$125
- Caldera Medical, Inc$34
What the payments were for
- Speaking & faculty fees$1,68024%
- Travel & lodging$83212%
- Food & beverage$4,62865%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 87 | $4,677 |
| Boston Scientific | 17 | $1,575 |
| Coloplast | 10 | $526 |
| Axonics, Inc. | 6 | $204 |
| Urovant Sciences Inc | 1 | $125 |
| Caldera Medical, Inc | 1 | $34 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,140 in reported general payments places this provider in the 65th percentile of 51 urogynecology and reconstructive pelvic surgery providers in Pennsylvania.
See all urogynecology and reconstructive pelvic surgery providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 58 | $29,940 |
| Estradiol | 103 | $6,506 |
| Trospium Chloride | 33 | $1,318 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 27 | $272 |
Paid to pharmacies, not to this prescriber.
Other urogynecology and reconstructive pelvic surgery in Allentown
- Vincent LucenteAllentown$798K
- Miles MurphyAllentown$54K
- Perrin DowningAllentown$9K
- Devon SmithAllentown$1K
- Heather GottliebNewtown$48K
- Michael BonidieMechanicsburg$39K
- Lily AryaPhiladelphia$34K
- Julie DroletYork$29K
- Alexander BrusckeQuakertown$24K
- Marc TogliaMedia$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.